Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Enrica Imbrogno · SciRah

Researcher profile · Semantic Scholar

Enrica Imbrogno

Share profile

Enrica Imbrogno — researcher profile on SciRah

h-index: 7
Works: 33
Citations: 284

Most-cited papers

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
E. Derenzini, C. Agostinelli, Enrica Imbrogno, I. Iacobucci +9 more
2015OncoTarget63 citations Open access
Semantic Scholar
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate
F. Scala, Elisa Brighenti, M. Govoni, Enrica Imbrogno +4 more
2016Oncogene57 citations Open access
Semantic Scholar
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
Andrea Ghelli Luserna di Rorá, N. Beeharry, Enrica Imbrogno, A. Ferrari +20 more
2018Journal of Hematology & Oncology42 citations Open access
Semantic Scholar
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
Andrea Ghelli Luserna Di Rorà, I. Iacobucci, Enrica Imbrogno, C. Papayannidis +9 more
2016OncoTarget37 citations Open access
Semantic Scholar
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
I. Iacobucci, Andrea Ghelli Luserna Di Rorà, M. Falzacappa, C. Agostinelli +19 more
2015Journal of Hematology & Oncology28 citations Open access
Semantic Scholar
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
Andrea Ghelli Luserna di Rorá, M. Bocconcelli, A. Ferrari, C. Terragna +14 more
2019Cancers25 citations Open access
Semantic Scholar
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
Andrea Ghelli Luserna di Rorá, M. Ghetti, Lorenzo Ledda, A. Ferrari +17 more
2021Cell Biology and Toxicology23 citations Open access
Semantic Scholar
Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma
E. Derenzini, I. Iacobucci, C. Agostinelli, Enrica Imbrogno +8 more
2015Experimental Hematology & Oncology5 citations Open access
Semantic Scholar
Abstract 5279: Metabolic profiling defines a new characterization of acute myeloid leukemia and identifiesNPM1-mutated cases as a distinct subgroup
G. Simonetti, A. Padella, Eugenio Fonzi, Martina Pazzaglia +16 more
2019Molecular and Cellular Biology / Genetics2 citations
Semantic Scholar
Abstract 2964: Pharmacological inhibition of WIP1 by GSK2830371 sensitizes AML cells to MDM2 inhibitor Nutlin-3a
M. Fontana, J. Nanni, G. Marconi, Martina Pazzaglia +12 more
2019Experimental and Molecular Therapeutics1 citations
Semantic Scholar
Abstract 3100: Blinatumomab is safe and effective in relapsed and MRD positive B-ALL CD19+ patients: The bologna compassionate program experience
G. Martinelli, S. Paolini, C. Cerchione, A. Santoro +22 more
2019Clinical research1 citations
Semantic Scholar
Abstract 2723: The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia
Andrea Ghelli Luserna di Rorà, I. Iacobucci, Enrica Imbrogno, E. Derenzini +7 more
20161 citations
Semantic Scholar
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia
A. Padella, G. Simonetti, Giulia Paciello, A. Ferrari +14 more
20151 citations
Semantic Scholar
Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
Andrea Ghelli Luserna Di Rorà, M. Ghetti, Lorenzo Ledda, A. Ferrari +17 more
2024Cell Biology and Toxicology0 citations Open access
Semantic Scholar
PS928 “3C-UP” A NEW ADULT PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA SUBGROUP: NOVEL MOLECULAR MARKERS
A. Ferrari, S. Vitali, V. Robustelli, G. A. L. D. Rora +25 more
2019HemaSphere0 citations Open access
Semantic Scholar
Abstract 2140: “3c-up” a new adult Philadelphia negative acute lymphoblastic leukemia subgroup: Novel molecular markers
A. Ferrari, S. Vitali, V. Robustelli, A. G. L. D. Rorà +23 more
2019Experimental and Molecular Therapeutics0 citations
Semantic Scholar
The Prolonged Inhibition of Chk1/Chk2 Kinases Enhances Genetic Instability and Compromises the Efficacy of Chemotherapy Against Acute Lymphoblastic Leukemia Cells
Andrea Ghelli Luserna di Rorá, A. Padella, M. Fontana, Eugenio Fonzi +7 more
2019Blood0 citations Open access
Semantic Scholar
PS931 ADULT TRIPLE NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA FUSION DETECTION: CHALLENGING AIM FOR PH- ALTERNATIVE THERAPIES
A. Ferrari, S. Vitali, Carmen Baldazzi, G. Ferrari +19 more
2019HemaSphere0 citations Open access
Semantic Scholar
RALE051: a novel established cell line of sporadic Burkitt lymphoma
A. L'Abbate, I. Iacobucci, A. Lonoce, Antonella Turchiano +10 more
2018Leukemia and Lymphoma0 citations Open access
Semantic Scholar
Abstract 2951: Gene expression profiling identifies new adult "triple-negative" acute lymphoblastic leukemia (ALL) subgroups
A. Ferrari, S. Vitali, V. Robustelli, A. G. L. D. Rorà +15 more
2018Clinical research0 citations
Semantic Scholar
Abstract 656: Distinct pattern of alterations in TP53 mutated/deleted and wild-type high risk acute myeloid leukemia (AML) patients: Identification of new "targetable" genes/pathways
A. Ferrari, Eugenio Fonzi, A. G. L. D. Rorà, M. Fontana +17 more
2018Clinical research0 citations
Semantic Scholar
A New Gene Expression Profile Signature CRLF2 Overexpression Based Identifies Novel Adult "Triple Negative" Acute Lymphoblastic Leukemia Subgroups
A. Ferrari, S. Vitali, V. Robustelli, Andrea Ghelli Luserna Di Rora +23 more
2018Blood0 citations Open access
Semantic Scholar
Abstract 1766: Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
A. Ferrari, Eugenio Fonzi, M. Fontana, A. G. L. D. Rorà +18 more
20170 citations
Semantic Scholar
Abstract 294: Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia
Andrea Ghelli Luserna di Rorà, I. Iacobucci, Enrica Imbrogno, A. Ferrari +7 more
20170 citations
Semantic Scholar
Adult Triple Negative ACUTE Lymphoblastic Leukemia Genome Wide Characterization
A. Ferrari, V. Robustelli, Eugenio Fonzi, Andrea Ghelli Luserna Di Rorà +18 more
20170 citations
Semantic Scholar
A COMBINED APPROACH TO DETECT RARE FUSION EVENTS IN ACUTE MYELOID LEUKEMIA
A. Padella, G. Simonetti, Giulia Paciello, A. Ferrari +13 more
20160 citations
Semantic Scholar
Mine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs
Andrea Ghelli Luserna di Rorà, I. Iacobucci, N. Beeharry, M. Falzacappa +8 more
20160 citations
Semantic Scholar
The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia
Andrea Ghelli Luserna di Rorà, I. Iacobucci, Enrica Imbrogno, E. Derenzini +8 more
20150 citations
Semantic Scholar
Abstract LB-105:In vitroandin vivosingle-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
I. Iacobucci, Andrea Ghelli Luserna di Rorà, M. Falzacappa, C. Agostinelli +16 more
20140 citations
Semantic Scholar
Abstract 3886: Clec12a: A new AML stem cell-associated antigen
V. Guadagnuolo, Enrica Imbrogno, Andrea Ghelli Luserna di Rorà, A. Padella +7 more
20140 citations
Semantic Scholar
DEREGULATED EXPRESSION OF CHECKPOINT KINASE 1 (CHK1) IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (BCR-ABL+ ALL) SUGGESTS A NEW THERAPEUTICTARGET
Andrea Ghelli Luserna di Rorà, I. Iacobucci, A. Ferrari, C. Papayannidis +20 more
20130 citations
Semantic Scholar
Abstract 705: Inhibition of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) is a novel therapeutic strategy in B- and T-Acute Lymphoblastic Leukemia (ALL).
I. Iacobucci, Andrea Ghelli Luserna di Rorà, M. Falzacappa, E. Derenzini +12 more
20130 citations
Semantic Scholar
Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma
E. Derenzini, C. Agostinelli, I. Iacobucci, Enrica Imbrogno +4 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Ferrari×31
Invite
A. Ferrari — researcher profile on SciRah
G. Martinelli×29
Invite
G. Martinelli — researcher profile on SciRah
C. Papayannidis×25
Invite
C. Papayannidis — researcher profile on SciRah
V. Robustelli×20
Invite
V. Robustelli — researcher profile on SciRah

×18

Invite

I. Iacobucci — researcher profile on SciRah

Invite

A. Padella — researcher profile on SciRah

G. Simonetti×16

Invite

G. Simonetti — researcher profile on SciRah

Andrea Ghelli Luserna Di Rorà×14

M. Abbenante×14

Invite

M. Abbenante — researcher profile on SciRah

Invite

G. Marconi — researcher profile on SciRah

Invite

M. Fontana — researcher profile on SciRah

E. Derenzini×11

Invite

E. Derenzini — researcher profile on SciRah